In general, such high energy ion beams are produced in thin solid targets by a strong electric field, which is, in turn, generated by a collective displacement of a large number of electrons. Such fields accelerate ions until charge neutrality is restored and they move together with electrons in a ballistic way. Until now, most of the experiments on laser-driven proton acceleration have been performed in the so-called Target Normal Sheath Acceleration regime (TNSA). The TNSA is based on the space-charge field generated at the rear surface of a micrometer-thick target. Such a quasi-electrostatic field is generated by high energy electrons, also known as “hot electrons”, which are accelerated by a high intensity laser at the target front surface, then cross the target bulk and attempt to escape in a vacuum from the rear side (see figure below) [Macchi et al].
The main direction proposed by the community of experts in this field is to improve the laser-accelerated ion features (maximum energy, yield, emittance, shot-to-shot stability, etc.) in order to propose reliable and very compact approaches to be used for societal applications, thus reducing the overall cost of standard acceleration facilities. The main goal of the ion beamline being developed at ELI Beamlines, ELIMAIA (ELI Multidisciplinary Applications of laser-Ion Acceleration), (add a hyperlink to the page on the “ELIMAIA beamline”) is to provide well-characterized, highly stable and tunable beams of particles accelerated by PW-class lasers to be offered to the user community for multidisciplinary applications. Medical applications are clearly the most attractive among those envisioned, since they might have a strong, positive impact on society. In particular, a potential use of laser-based hadrontherapy facilities is currently under investigation at the international level [ELIMED Workshop].
Schematic representation of the TNSA mechanism for proton acceleration (side view).
The ELIMAIA beamline will allow user to investigate multidisciplinary applications using laser driven ion beams, such as in-vitro radiation biology and pre-clinical studies within the ELIMED international cooperation.
ELIMAIA will be one of the key secondary source target areas of the ELI Beamlines facility. The proposed technological and scientific solutions for the implementation of the ELIMAIA beamline is the result of a complex investigation carried out in the last several years with the main goal of fulfilling the specific requirements that have been coming from the international user community.